FDA Authorises Restart of the COVID-19 AZD1222 Vaccine US Phase III Trial 27/10/2020 mediabest Medications 23 October 2020 — Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed across the world with regulators Read more
